Brinker Capital Investments
PFE icon

Brinker Capital Investments’s Pfizer PFE Stock Holding History

Brinker Capital Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$28 – 2061
2026
Q1 		$28 Buy
+1
New +$27 ﹤0.01% 2000

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brinker Capital Investments's PFE Position: Q2 2026 in Review

Brinker Capital Investments reduced its Pfizer (PFE) stake by 6% in Q2 2026, selling an estimated $704K and leaving 419,584 shares worth $10.1M. The position accounts for 0.08% of the portfolio, ranked #218.

Brinker Capital Investments first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $27.1M in Q1 2023. 2,843 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Brinker Capital Investments held 419,584 shares of Pfizer worth $10.1M as of Q2 2026.
  • Brinker Capital Investments sold 26,907 Pfizer shares in Q2 2026, an estimated $704K.
  • Pfizer made up 0.08% of Brinker Capital Investments's portfolio in Q2 2026, its #218 holding.
  • Brinker Capital Investments first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Brinker Capital Investments's Pfizer position peaked at $27.1M in Q1 2023.
  • 2,843 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.